Genolution

Genolution Payout Ratio

The Dividend Payout Ratio of Genolution (225220.KQ) as of Oct 22, 2026 is 10.53 %. In the previous year, Dividend Payout Ratio was 5.17 % — a change of 103.48% (higher).

Payout Ratio

10.53 %

YoY

103.48%

Last updated:

Dividend Payout Ratio of Genolution is 2021 10.53 % . Dividend Payout Ratio of Genolution was 2020 5.17 % . It decreases by 103.48% higher compared to the previous year.

The payout ratio is around 8% of earnings.

The Genolution Payout Ratio history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Payout Ratio
Date
Payout Ratio
Jan 1, 2018
7.85 KRW
Jan 1, 2019
7.85 KRW
Jan 1, 2020
5.17 KRW
Jan 1, 2021
10.53 KRW
Jan 1, 2022
7.85 KRW
Jan 1, 2023
7.85 KRW
Jan 1, 2024
8.74 KRW
Jan 1, 2025
8.15 KRW
The Genolution Payout Ratio history
YEARPayout RatioYoY
8.15 %-6.80%
8.74 %+11.37%
7.85 %0.00%
7.85 %-25.43%
10.53 %+103.48%
5.17 %-34.10%
7.85 %0.00%
7.85 %0.00%
7.85 %0.00%
7.85 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Genolution Stock analysis

What does Genolution do? Genolution Inc develops automated nucleic acid extraction devices, nucleic acid extraction reagents, and molecular diagnostic products. The company also offers ribonucleic acid interference services. Its products are distributed domestically and internationally, serving customers in the biotechnology and healthcare sectors. The firm generates revenue through the sale of these products and services to research institutions, laboratories, and healthcare providers. The company's core offerings include nucleic acid extractors, reagents, and diagnostic products, which are used in molecular biology and medical diagnostics. Genolution Inc targets biotech firms, hospitals, and research facilities as key buyers of its technology. Its domestic market presence complements its international distribution channels. Genolution Inc's business model relies on selling its automated extraction devices and reagents to customers requiring efficient nucleic acid processing solutions. The company's molecular diagnostic products cater to healthcare applications, while its ribonucleic acid interference services support advanced research needs. Revenue streams are derived from both product sales and service contracts within the biotechnology industry. Genolution is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genolution stock

Dividend Payout Ratio of Genolution is 10.53 % in 2021.

Dividend Payout Ratio of Genolution changed from 5.17 % to 10.53 %, representing a 103.48% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Dividend Payout Ratio Genolution since 2006 – with annual values, charts, and detailed analysis.

The payout ratio measures the percentage of net income distributed as dividends. A sustainable payout ratio leaves room for reinvestment and growth.

Dividend Payout Ratio's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Dividend Payout Ratio's Genolution historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Genolution

All Key Metrics — Genolution